A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first‐line therapy for patients with breast cancer ( CBCRT 01)-Reference-Cited by-同舟云学术

A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first‐line therapy for patients with breast cancer ( CBCRT 01)

Published:2017-12-23 Issue:10 Volume:142 Page:2130-2138
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Chen Jianghao¹^ORCID,Yao Qing¹,Huang Meiling¹,Wang Bo²,Zhang Juliang¹,Wang Ting¹,Ming Yu³,Zhou Xiaodong³,Jia Qianxin⁴,Huan Yi³,Wang Jing⁵,Wang Ling¹

Affiliation:

1. Department of Thyroid, Breast and Vascular SurgeryXijing Hospital, Fourth Military Medical UniversityXi'an China

2. Department of EpidemiologyFourth Military Medical UniversityXi'an China

3. Department of UltrasoundXijing Hospital, Fourth Military Medical UniversityXi'an China

4. Department of RadiologyXijing Hospital, Fourth Military Medical UniversityXi'an China

5. Department of Nuclear MedicineXijing Hospital, Fourth Military Medical UniversityXi'an China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shaanxi Province

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.31217

Reference25 articles.

1. Dynamic Contrast-Enhanced MR Imaging in a Phase Ⅱ Study on Neoadjuvant Chemotherapy Combining Rh-Endostatin with Docetaxel and Epirubicin for Locally Advanced Breast Cancer

2. Current and future role of neoadjuvant therapy for breast cancer

3. Preoperative therapy: what, when and for whom?

4. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902

5. Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety Analysis of Recombinant Human Endostatin (Endostar) Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer: A 2-Center Retrospective Study;Technology in Cancer Research & Treatment;2024-01

2. Treating radiation‑related nasopharyngeal necrosis with endostar in patient with nasopharyngeal carcinoma: A report of two cases and a literature review;Molecular and Clinical Oncology;2023-06-13

3. Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel as First Line Treatment in Women with Advanced Breast Cancer;Journal for Research in Applied Sciences and Biotechnology;2023-06-12

4. A microphysiological model of bone development and regeneration;Biofabrication;2023-06-06

5. Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies;Biomedicines;2023-02-27